BIOVANCE is an allograft-material made from donated human tissue-used as a covering that supports the repair of damaged tissue. BIOVANCE is derived from the inner lining of the human placenta, which helps nourish a baby during pregnancy.

​

The placentas used in the manufacture of BIOVANCE are donated by consenting women following a healthy, full-term pregnancy and live birth. All placenta donors are tested for infectious diseases before the donation process.

 

Once the baby of an approved donor has been delivered, the placenta is collected and sent to a Celularity lab for purification and processing.

 

At the lab, the placenta is washed and sterilized, and all of the donor's living cells are removed. BIOVANCE is regulated by the United States Food and Drug Administration (FDA) and the processing facility is accredited by the American Association of Blood Banks (AABB).